Table 1 The characteristics of patient in this study
Total (n = 186) | Patients with anti-HCV positive (n = 93) | Patients with anti-HCV negative (n = 93) | P | |
|---|---|---|---|---|
Age (year) | 53.3 (44.8–62.3) | 54.0 (44.8–62.6) | 52.7 (45.0–62.0) | 0.415 |
Sex | 0.358 | |||
Male | 120 (64.5) | 63 (67.7) | 57 (61.3) | |
Female | 66 (35.5) | 30 (32.3) | 36 (38.7) | |
BMI (kg/m2) | 22.0 (20.1–24.6) | 22.1 (19.3–24.5) | 21.9 (20.2–24.8) | 0.206 |
IDU | 20 (10.8) | 15 (16.1) | 5 (5.4) | 0.031* |
MSM | 6(3.2) | 2(2.2) | 4 (4.3) | 0.682 |
Dialysis vintage (years) | 7.0 (4.0–10.3) | 7.1 (4.0–13.0) | 5.1 (4.0–9.0) | 0.013* |
ALT (U/L) | 16.0 (11.3–23.0) | 19.5 (14.0–27.5) | 14.0 (11.0–21.0) | 0.001* |
AST (U/L) | 18.5 (13.0–26.3) | 24 (17.0–32.5) | 16 (12.0–21.0) | < 0.001* |
Cr (mg/dL) | 9.2 (7.2–11.2) | 9.1 (6.9–11.1) | 9.3 (7.2–11.4) | 0.655 |
APRI | 0.23 (0.16–0.32) | 0.29 (0.20–0.42) | 0.20 (0.14–0.29) | < 0.001* |